• No results found

Preoperative physiotherapy for the prevention of respiratory complications after upper abdominal surgery: pragmatic, double blinded, multicentre randomised controlled trial

N/A
N/A
Protected

Academic year: 2020

Share "Preoperative physiotherapy for the prevention of respiratory complications after upper abdominal surgery: pragmatic, double blinded, multicentre randomised controlled trial"

Copied!
15
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Fig 1 | Flow of patients through trial. UAS=upper abdominal surgery. PAC=preadmission clinic
Table 1 | Baseline demographic and clinical characteristics of the study population. Values are numbers (percentages) unless stated otherwise
Table 2 | Postoperative clinical events and complications between groups
Table 3 | Primary and secondary outcomes. Values are numbers (percentages) unless stated otherwise
+4

References

Related documents

The power transformer protective relay should block the tripping during magnetizing inrush and rapidly initiate the tripping during internal faults .In this paper,

Phlogiston; Chemical Revolution; Lavoisier; reference;

Muslims in today’s global scenario must commit themselves to building the organization that implement cleaner or greener Islamic management model in order to

Totally twenty four fresh faecal samples (six samples of each from indigenous chicken, goat, broiler and farm goat) were collected from different locations in Pudukkottai and

In order to examine the effects of task sequence and complexity in enhancing EFL learners’ speaking ability in three different areas including accuracy, fluency and

Annual fatality rates were calculated by dividing the number of deaths that resulted from severe cases of HFMD/herpan- gina for children who were younger than 15 years by the number

baumannii causing nosocomial infections in burned patients which can be important for hospital infection.. prevention systems

Survival analysis showed no significant association between DFNA5 expression and 5-year OS time, neither microarray nor RNA-seq, for all breast adenocarcinoma patients or ductal